Immunoregulatory effects of RGMb in gut inflammation
Graft-versus-host disease (GvHD) is a major complication after allogeneic hematopoietic cell transplantation (HCT). Current strategies to prevent GvHD with immunosuppressive drugs carry significant morbidity and may affect the graft-versus-tumor (GVT) effect. Inflammatory bowel disease (IBD) is an i...
Main Authors: | Magdiel Pérez-Cruz, Bettina P. Iliopoulou, Katie Hsu, Hsin-Hsu Wu, Tom Erkers, Kavya Swaminathan, Sai-Wen Tang, Cameron S. Bader, Neeraja Kambham, Bryan Xie, Rosemarie H. Dekruyff, Gordon J. Freeman, Everett Meyer |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-11-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2022.960329/full |
Similar Items
-
Targeting RGMb interactions: Discovery and preclinical characterization of potent anti-RGMb antibodies blocking multiple ligand bindings
by: Maria Meira, et al.
Published: (2024-12-01) -
Blockade of TIM-1 on the donor graft ameliorates graft-versus-host disease following hematopoietic cell transplantation
by: Bettina P. Iliopoulou, et al.
Published: (2019-11-01) -
Acute graft versus host disease 1976–2020: reduced incidence and predictive factors
by: Alessandra Di Francesco, et al.
Published: (2024-01-01) -
Repulsive Guidance Molecule b Deficiency Induces Gut Microbiota Dysbiosis and Increases the Susceptibility to Intestinal Inflammation in Mice
by: Ying Shi, et al.
Published: (2021-04-01) -
Non-Invasive Diagnosis of Pediatric Intestinal Graft-Versus-Host Disease: A Case Series
by: Manuela Spadea, et al.
Published: (2022-03-01)